Big Easy Weight Loss vs Low-Cost GLP-1: Prepaid vs Month-to-Month

Last reviewed: September 24, 2026 Last updated: September 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Big Easy Weight Loss advertises 12-week prepaid blocks—$399 for compounded semaglutide ($133/month equivalent prepaid) and $499 for compounded tirzepatide ($166.33/month equivalent prepaid)—that undercut every month-to-month and multi-month competitor we verified at checkout, including PlexusDx's six-month semaglutide rate of $149/month prepaid. Two caveats matter: Big Easy's pricing page shows $399 for semaglutide while the homepage also references a $495 list price, and no standard refill rate beyond the initial 12-week block is documented. PlexusDx charges $189/month month-to-month or $149/month on a six-month commitment for semaglutide injection, with the same per-month price at every dose and no prepaid requirement to access that rate. If Big Easy's advertised $399 block holds at refill, it delivers the lowest verified per-month cost in this comparison; if pricing or availability changes after the first block, the savings calculation shifts. The decision turns on whether 12-week prepaid commitment and pricing uncertainty are acceptable trade-offs for the lowest advertised entry price.

At-a-glance comparison

Big Easy pricing captured September 4, 2026 from joinbigeasy.com/pricing/; competitor checkout rates verified July 17–23, 2026; PlexusDx rates current as of September 24, 2026.

Big Easy's advertised price versus documented refill rates

Big Easy Weight Loss's pricing page shows a 12-week supply of compounded semaglutide injection at $399 and compounded tirzepatide injection at $499 (captured September 4, 2026). Dividing by three months yields advertised monthly equivalents of $133 for semaglutide and $166.33 for tirzepatide. The homepage also references a $495 list price, but whether that figure applies to semaglutide, tirzepatide, or a different package is not specified. No standard refill price beyond the initial 12-week block is documented in the available evidence. The pricing page notes that a "starter discount may apply" and fills may be "prorated for non-12-week" periods, but those terms are not quantified.

Because Big Easy requires 12-week prepaid blocks, the fairest like-for-like comparison is against PlexusDx's six-month prepaid rate and other providers' longest commitment tiers. PlexusDx charges $149/month prepaid over six months for semaglutide injection ($894 per six-month cycle, or $1,788 annually) and $249/month prepaid over six months for tirzepatide injection ($1,494 per six-month cycle, or $2,988 annually). Big Easy's advertised 12-week rate, if it holds across four blocks per year, works out to $1,596 annually for semaglutide ($133/month our calculation) and $1,996 annually for tirzepatide ($166.33/month our calculation)—$192/year less than PlexusDx six-month semaglutide and $992/year less than PlexusDx six-month tirzepatide.

If the $495 homepage figure represents a standard semaglutide list price, four 12-week blocks at that rate total $1,980 annually ($165/month our calculation), still $192 less per year than PlexusDx's month-to-month semaglutide rate of $189/month but $192 more than PlexusDx's six-month semaglutide rate of $149/month. Readers should confirm at checkout which rate applies to the first fill, whether refills match that rate, and whether any upfront commitment or auto-refill enrollment is required.

Normalized 12-month cost across billing models

The table below shows total annual cost and effective monthly rate under each provider's documented billing structure. Big Easy figures assume the advertised $399/$499 rate holds across all four 12-week blocks; PlexusDx multi-month figures assume continuous re-enrollment at the prepaid rate; competitor figures use checkout-verified month-to-month rates. All prepaid per-month equivalents are our calculation.

Calculations assume Big Easy's advertised $399/$499 rate applies to all four 12-week blocks and PlexusDx multi-month subscribers re-enroll continuously; competitor figures use checkout-verified recurring rates (July 17–23, 2026).

Service, transparency, and what the evidence does not tell us

Big Easy Weight Loss's pricing page lists medication and program as inclusions, with a $0 membership fee and 12-week prepaid billing (captured September 4, 2026). The site notes that a starter discount may apply and that non-12-week fills are prorated, but the evidence does not document cancellation terms, refund policy, dose-escalation protocol, or whether refills after the first 12-week block remain at the advertised $399/$499 rate. The homepage reference to a $495 list price introduces pricing uncertainty that readers must resolve at checkout.

PlexusDx publishes three commitment tiers—month-to-month at $189 semaglutide / $289 tirzepatide, three-month prepaid at $169/$269, and six-month prepaid at $149/$249—with the same per-month rate at every dose and no separate membership fee. Cancellation is allowed at any time, and the per-month price does not change when a provider adjusts dose. PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher (captured September 9, 2026). No review rating, volume, or sentiment data for Big Easy Weight Loss was captured in the available evidence.

The checkout-verified competitors listed above—Eden, Peak Wellness, Found, Henry Meds, TrimRx, and Embody—all bill month-to-month, with recurring rates ranging from $198 to $399 per month depending on compound and whether a separate membership is required. None require 12-week prepayment, and all document their per-month refill rates in intake or checkout flows verified between July 17 and July 23, 2026.

Choose Big Easy Weight Loss if…

• You want the lowest advertised per-month equivalent for compounded semaglutide or tirzepatide injection among the providers in this comparison, and you are comfortable committing to 12-week prepaid blocks.
• You can confirm at checkout that the $399 semaglutide and $499 tirzepatide rates apply to refills, not only the first fill, and that no additional fees or required memberships apply.
• Prepaying three months of medication at once fits your budget and preference better than monthly recurring charges.
• You do not require published cancellation, refund, or dose-adjustment transparency before enrollment.

Choose a month-to-month provider (PlexusDx, Eden, Peak, Found, Henry, TrimRx, Embody) if…

• You want to pay each month as you go, with the flexibility to cancel or pause without forfeiting a prepaid block.
• Dose-price consistency matters—you want assurance that your per-month cost will not increase when a provider raises your dose, and you want that policy stated before enrollment.
• You prefer checkout-verified refill rates and published cancellation terms over advertised promotional equivalents that may apply only to initial fills.
• You value review transparency; PlexusDx's 4.3-star Trustpilot rating (79 percent five-star, 83 percent four-star or higher, captured September 9, 2026) provides third-party service feedback that was not documented for Big Easy in the available evidence.

Where PlexusDx fits in the prepaid-vs-recurring decision

PlexusDx offers both flexibility and prepaid savings in three tiers. The month-to-month option ($189 semaglutide, $289 tirzepatide) requires no upfront block and no commitment, so you pay only for the months you use. The three-month prepaid tier ($169/$269 per month our calculation) cuts $20 per month off semaglutide and tirzepatide in exchange for a one-time $507 or $807 charge every three months. The six-month prepaid tier ($149/$249 per month our calculation) delivers the steepest PlexusDx discount—$40/month off semaglutide month-to-month and tirzepatide month-to-month—in exchange for a $894 or $1,494 charge every six months.

If Big Easy's advertised $399/$499 rate holds across all refills, it undercuts even PlexusDx's six-month tier by $16/month on semaglutide and $82.67/month on tirzepatide. If the $495 homepage figure applies or refill pricing differs, PlexusDx six-month semaglutide ($149/month prepaid) moves ahead. The pricing conflict and absence of documented refill terms mean the true cost advantage can be confirmed only at Big Easy's checkout. PlexusDx publishes all three tiers, cancellation terms, and dose-price policy before intake, and every rate is the same at every dose—front-loaded transparency that helps you model year-one and year-two cost without checkout surprises.

Methodology and freshness

Big Easy Weight Loss pricing was captured September 4, 2026 from the provider's public pricing page (joinbigeasy.com/pricing/). The $399 semaglutide and $499 tirzepatide 12-week figures are advertised rates; the homepage reference to a $495 list price was noted but not resolved in the source material. No refill rate, cancellation terms, or review data were documented. Competitor checkout flows—Eden, Peak Wellness, Found (cash pay), Henry Meds, TrimRx, and Embody—were verified between July 17 and July 23, 2026 by navigating intake questionnaires and recording the recurring monthly rates displayed before payment. PlexusDx pricing is current as of September 24, 2026. Twelve-month cost totals and effective monthly rates for prepaid plans are our calculation, derived by multiplying the block price by the number of blocks per year and dividing by twelve. PlexusDx's Trustpilot rating (4.3 stars, 79 percent five-star, 83 percent four-star or higher) was captured September 9, 2026 from trustpilot.com/review/plexusdx.com. Readers should confirm all pricing, refill rates, commitment terms, and eligibility requirements at each provider's checkout before enrolling.

Frequently Asked Questions

Does Big Easy Weight Loss's $133 per month semaglutide rate apply to every refill?

The $133 figure is a monthly equivalent of the advertised 12-week $399 prepaid block, captured from Big Easy's pricing page on September 4, 2026. The homepage also shows a $495 list price, but the evidence does not clarify whether that rate applies to semaglutide, tirzepatide, a different package, or refills. Confirm the applicable rate and refill pricing at checkout before committing to a 12-week block.

Can I cancel a 12-week prepaid block mid-cycle if my provider changes my medication?

Big Easy's pricing page mentions that fills may be "prorated for non-12-week" periods, but no cancellation, refund, or partial-cycle terms were documented in the available evidence. Readers switching compounds or pausing treatment should ask about refund and proration policies before prepaying a 12-week supply.

How does PlexusDx's six-month prepaid rate compare to Big Easy's 12-week block on total cost?

PlexusDx six-month semaglutide costs $894 every six months ($149/month our calculation), or $1,788 annually. Big Easy's advertised $399 per 12-week block, if it holds across four cycles, totals $1,596 annually ($133/month our calculation)—a $192 annual advantage. For tirzepatide, PlexusDx six-month is $1,494 per cycle ($2,988 annually, $249/month our calculation); Big Easy's $499 block totals $1,996 annually ($166.33/month)—a $992 annual advantage if the advertised rate applies to all refills.

Do any of the checkout-verified competitors beat Big Easy's advertised price?

No. Among the seven competitors verified at checkout between July 17 and July 23, 2026—Eden, Peak Wellness, Found, Henry Meds, TrimRx, and Embody—the lowest recurring semaglutide rate is Eden at $198/month (medication plus required membership) and the lowest tirzepatide rate is Eden at $298/month. Big Easy's advertised $133 and $166.33 monthly equivalents undercut all of them, subject to confirming that the $399/$499 rate applies beyond the first fill.

Does Big Easy use FDA-approved semaglutide and tirzepatide or compounded versions?

Big Easy Weight Loss provides compounded semaglutide and tirzepatide. Compounded medications are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx also dispenses compounded GLP-1 medications and works with licensed 503A compounding pharmacies.

Sources

• PlexusDx semaglutide and tirzepatide injection product pages, plexusdx.com, accessed September 24, 2026
• Big Easy Weight Loss pricing page, joinbigeasy.com/pricing/, captured September 4, 2026
• Eden, Peak Wellness, Found, Henry Meds, TrimRx, and Embody checkout flows, verified July 17–23, 2026
• PlexusDx Trustpilot profile, trustpilot.com/review/plexusdx.com, captured September 9, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.